2011-09-01
Atrial Natriuretic Peptide (ANP) in early pregnancy is associated with development of preeclampsia in type 1 diabetes
Publication
Publication
Diabetes Research and Clinical Practice , Volume 93 - Issue 3
The vasoactive markers of cardiac overload Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) are elevated in preeclampsia. This study documents higher ANP concentrations as early as at 9 weeks in type 1 diabetic women subsequently developing preeclampsia suggesting that preeclampsia is associated with cardiovascular changes in early pregnancy.
| Additional Metadata | |
|---|---|
| , , , , , | |
| doi.org/10.1016/j.diabres.2011.06.007, hdl.handle.net/1765/33628 | |
| Diabetes Research and Clinical Practice | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Ringholm, L., Pedersen-Bjergaard, U., Thorsteinsson, B., Boomsma, F., Damm, P., & Mathiesen, E. (2011). Atrial Natriuretic Peptide (ANP) in early pregnancy is associated with development of preeclampsia in type 1 diabetes. Diabetes Research and Clinical Practice, 93(3). doi:10.1016/j.diabres.2011.06.007 |
|